Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

368
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

664
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
664
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

315
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

439
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
439
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

705
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
705
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

944
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
944

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Model-Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients.

Clinical pharmacology and therapeutics·2026
Same author

The Coming of Age of Model-Informed Precision Therapeutics for Children.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2025
Same author

Building a Beta-Lactam Model-Informed Precision Dosing Service in a Quaternary Care Children's Hospital.

Clinical and translational science·2025
Same author

Supporting parents with cancer: An adult psychosocial and palliative care provider needs assessment.

Journal of psychosocial oncology·2025
Same author

Microsensor Array for the Electrochemical Analysis of Hydroxyurea in Blood Samples of Children Affected by Sickle Cell Anemia.

Analytical chemistry·2025
Same author

Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations.

Blood advances·2025

Related Experiment Video

Updated: Mar 21, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

14.1K

Measuring Medication Adherence in Pediatric Cancer: An Approach to Validation.

Jennifer M Rohan1,2, Tsuyoshi Fukuda3,4, Melissa A Alderfer5,6

  • 1Department of Psychology, University of Cincinnati, Cincinnati, OH, USA.

Journal of Pediatric Psychology
|May 19, 2016
PubMed
Summary

This study found that measuring 6-mercaptopurine (6MP) metabolites in pediatric cancer patients prospectively predicts medication adherence. Low metabolite levels correlated with lower adherence, aiding clinical interventions.

Keywords:
adherencecancermetabolitespediatricspharmacology

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

31.0K

Related Experiment Videos

Last Updated: Mar 21, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

14.1K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

31.0K

Area of Science:

  • Pharmacology
  • Pediatric Oncology
  • Clinical Pharmacy

Background:

  • Medication adherence is crucial for pediatric cancer treatment efficacy.
  • Accurate measurement of adherence to 6-mercaptopurine (6MP) is challenging.
  • Existing adherence measures have limitations in pediatric populations.

Purpose of the Study:

  • To prospectively evaluate the relationship between pharmacological and behavioral measures of 6MP adherence.
  • To validate metabolite concentrations as a reliable indicator of 6MP intake.
  • To identify adherence patterns in pediatric cancer patients.

Main Methods:

  • A multisite cohort of 139 pediatric cancer patients was studied.
  • Pharmacological adherence was assessed via metabolite concentrations.
  • Behavioral adherence was monitored using electronic methods over 15 months.

Main Results:

  • Three metabolite profiles were identified, with 40.8% showing low levels indicative of nonadherence or suboptimal therapy.
  • Adequate adherence was indicated by metabolite clusters in 59.2% of patients.
  • Patients with low metabolite levels consistently exhibited lower behavioral adherence rates.

Conclusions:

  • This is the first prospective study to validate pharmacological adherence measures against behavioral measures in pediatric cancer patients.
  • Metabolite profiling offers a reliable method to assess 6MP adherence.
  • Integrating multiple adherence measures can improve clinical care and identify patients requiring intervention.